Neuropsychological correlates of suboptimal adherence to metformin

Journal of Behavioral Medicine

Volumn 26, Issue 4, 2003, Pages 349-360

  Rosen, Marc I ^a,b   Beauvais, John E ^a,b   Rigsby, Michael O ^a   Salahi, Jamelah T ^a,b   Ryan, Caitlin E ^a,b   Cramer, Joyce A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Adherence, trail making test, diabetes mellitus; Neuropsychology; Patient compliance

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ADULT; AGE; AGED; ARTICLE; COGNITION; DRUG MONITORING; DRUG USE; ETHNOLOGY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT COUNSELING; STROOP TEST;

ADULT; AGED; AGED, 80 AND OVER; APPOINTMENTS AND SCHEDULES; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, VETERANS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 0038375824     PISSN: 01607715     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024257027839     Document Type: Article

References (26)

1. Eldred, L. J., Wu, A. W., Chaisson, R. E., and Moore, R. D. (1998). Adherence to pneumocystis prophylaxis in HIV disease. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18: 117-125.
2. Ellis, J. (1998). Prospective memory and medication taking. In Myers, L. B., and Midence, K. (Eds.), Adherence to Treatment in Medical Conditions, Harwood Academic Publishers, Amsterdam, The Netherlands, chap. 22, p. 525ff.
3. Fields, R. B. (1998). The dementias. In Snyder, P. J., and Nussbaum, P. D. (Eds.), Clinical Neuropsychology: A Pocket Handbook for Assessment, American Psychological Association, Washington, DC, pp. 211-239.
4. Folstein, M. F., Folstein, S. E., and Mchugh, P. R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (3): 189-198.
5. Golden, C. J. (1978). The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses, Stoelting Company, Chicago, IL.
6. Ickovics, J. R., and Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. J. Clin. Epidemiol. 50(4): 385-391.
7. Isaac, L. M., and Tamblyn, R. M. (1993). Compliance and cognitive function: Methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist 33(6): 772-781.
8. Kalichman, S. C., Ramachandran, B., and Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J. Gen. Intern. Med. 14(5): 267-273.
9. Lafayette Instrument Company (n.d). Instructions for the Grooved Pegboard Test, Lafayette Instrument Company, Lafayette, IN.
10. Ley, P. (1985). Doctor-patient communication: Some quantitative estimates of the role of cognitive factors in non-compliance. J. Hypertens. (Suppl.) 3(1): 51-55.
11. Mason, B. J., Matsuyama, J. R., and Jue, S. G. (1995). Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ. 21: 52-57.
12. Monane, M., Bohn, R. L., Gurwitz, J. H., Glynn, R. J., and Avorn, J. (1994). Noncompliance with congestive heart failure therapy in the elderly. Arch. Intern. Med. 154: 433.
13. Newell, S. A., Bowman, J. A., and Cockburn, J. D. (1999). A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment keeping in the treatment of cardiovascular disease. Prev. Med. 29: 535-548.
14. Okuno, J., Yanagi, H., and Tomura, S. (2001). Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur. J. Clin. Pharmacol. 57(98): 589-594.
15. Paes, A. H. P., Bakker, A., and Soe-Agnie, C. J. (1997). Impact of dosage frequency on patient compliance. Diabetes Care 20: 1512-1517.
16. Park, D. C., Hetzog, C., Leventhal, H., Morrell, R. W., Leventhal, E., Birchmore, D., Martin, M., and Bennett, J. (1999). Medication adherence in rheumatoid arthritis patients: Older is wiser. J. Am. Geriatr. Soc. 47(2): 172-183.
17. Raynor, D. K. (1993). Effects of computer generated reminder charts on patients' compliance. BMJ 306: 1158-1161.
18. Reitan, R. M., and Wolfson, D. (1985). The Halstead-Reitan Neurological Test Battery: Theory and Clinical Interpretation, Neuropsychology Press, Tucson, AZ.
19. Ryan, C. M. (2001). Diabetes-associated cognitive dysfunction. In Waldstein, S. R., and Elias, M. F. (Eds), Neuropsychology of Cardiovascular Disease, Erlbaum, Hillsdale, NJ, pp. 61-82.
20. Salas, M., In't Veld, B. A., Van der Linden, P. D., Hofman, A., Breteler, M., and Stricker, B. H. (2001). Impaired cognitive function and compliance with antihypertensive drugs in elderly: The Rotterdam study. Clin. Pharmacol. Ther. 70(6): 561-566.
21. Santiago, J. V., Davis, J. E., and Fisher, F. (1978). Hemoglobin Alc levels in a diabetes detection program. J. Clin. Endocrinol. Metab. 47(3): 578-580.
22. Sherbourne, C. D., Hays, R. D., Ordway, L., DiMatteo, M. R., and Kravitz, R. L. (1992). Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study. J. Behav. Med. 15: 447-468.
23. Spriet, A., Beiler, D., Dechorgnat, J., and Simon, P. (1980). Adherence of elderly patients to treatment with pentoxifylline. Clin. Pharmacol. Ther. 27(1): 1-8.
24. Strachan, M. W. J., Deary, I. J., Ewing, R. M. E., and Frier, B. M. (1997). Is type 2 (non-insulin dependent) diabetes mellitus associated with an increased risk of cognitive dysfunction? Diabetes Care 20: 438-445.
25. Straka, R. J., Fish, J. T., Benson, S. R., and Suh, J. T. (1996). Magnitude and nature of noncompliance with isosorbide dinitrate for ischemic heart disease. Clin. Pharmacol. Ther. 59(2): 191.
26. Wechsler, D. (1981). Wechsler Adult Intelligence Scale - Revised, Psychological Corporation, New York.